FDG-PET/CT helps determine risk of vascular events in cancer patients

10/11/2009 | AuntMinnie.com (free registration)

A German study on patients who underwent FDG-PET/CT scans for neoplastic disease found that "the combination of a calcified plaque sum greater than 15 and a mean TBR of greater than 1.7 identified patients at highest risk for a future vascular event." The finding suggests that patients undergoing PET/CT tests for cancer diagnosis or staging could also know their atherogenic risk, the researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA